← Leaderboards
Gretchen M Unger
Genesegues, Inc.
$1,676,717
Attributed
$1,756,208
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $300K · FY2006–14$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,756,208 · 6
By mechanism
R43$1,756,208 · 6
Top collaborators
- John M Nickerson1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCapsule (Pharmacologic)DoseIn VivoLigandsNanometerTissuesEncapsulatedUptakePlasmidsGene TherapySiteGenesHyaluronanPlasmid DnaTechnologyBaseMediatingPharmaceutical PreparationsPathway InteractionsClinicImmuneClinically RelevantImmune Response
Grant awards (9)
Nanocapsule-mediated topical delivery of VLP-generating Dengue DNA vaccine$300,000
R43 · FY2014 · AI · contact PI
Nanocapsule-mediated topical delivery of VLP-generating Dengue DNA vaccine$300,000
R43 · FY2013 · AI · contact PI
Topical delivery of nanoencapsulated plasmid DNA to posterior ocular targets$158,983
R43 · FY2012 · EY · contact PI
Nonviral vehicles targeting liver cell-subtypes for nuclear delivery via rafts$203,015
R43 · FY2010 · DK · contact PI
Nonviral vehicles targeting liver cell-subtypes for nuclear delivery via rafts$203,015
R43 · FY2009 · DK · contact PI
Tumor-targeted delivery of siRNA via sub-50 nanometer capsules$99,746
R43 · FY2007 · CA · contact PI
Tumor-targeted delivery of siRNA via sub-50 nanometer capsules$99,729
R43 · FY2006 · CA · contact PI
S50 nanocapsules for transcutaneous DNA vaccination$146,661
R43 · FY2004 · AI
Antisense gene therapy with tumor-targeted nanocapsules$245,059
R43 · FY2003 · CA